{"id":20948,"date":"2021-05-05T11:03:33","date_gmt":"2021-05-05T11:03:33","guid":{"rendered":"https:\/\/neuraxpharm.com\/it\/portfolio\/buccolam"},"modified":"2022-09-12T15:08:28","modified_gmt":"2022-09-12T15:08:28","slug":"buccolam","status":"publish","type":"portfolio-products","link":"https:\/\/www.neuraxpharm.com\/it\/portfolio\/buccolam","title":{"rendered":"Buccolam"},"content":{"rendered":"<p>Trattamento di crisi convulsive acute prolungate, in bambini e adolescenti (da 3 mesi a &lt; 18 anni). BUCCOLAM deve essere usato solo da genitori\/persone che prestano assistenza in pazienti che abbiano ricevuto una diagnosi di epilessia.<\/p>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Per i bambini dai 3 ai 6 mesi, il trattamento deve avvenire in un ambiente ospedaliero, dove \u00e8 possibile il monitoraggio e sono disponibili strutture di rianimazione.<\/span><\/span><\/p>\n<div style=\"width: 800px;\" class=\"wp-video\"><video class=\"wp-video-shortcode\" id=\"video-20948-1\" width=\"800\" height=\"450\" preload=\"metadata\" controls=\"controls\"><source type=\"video\/mp4\" src=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/5\/2021\/05\/01092715\/mst-neuraxpharm-buccolam-it.mp4?_=1\" \/><a href=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/5\/2021\/05\/01092715\/mst-neuraxpharm-buccolam-it.mp4\">https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/5\/2021\/05\/01092715\/mst-neuraxpharm-buccolam-it.mp4<\/a><\/video><\/div>\n","protected":false},"featured_media":18851,"parent":0,"template":"","active-substance":[175],"product-category":[173],"therapeutic-area":[176],"class_list":["post-20948","portfolio-products","type-portfolio-products","status-publish","has-post-thumbnail","hentry","active-substance-midazolam","product-category-linea-farmaceutica","therapeutic-area-epilessia"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.6 (Yoast SEO v26.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Buccolam - Neuraxpharm Italia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/it\/portfolio\/buccolam\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Buccolam\" \/>\n<meta property=\"og:description\" content=\"Trattamento di crisi convulsive acute prolungate, in bambini e adolescenti (da 3 mesi a &lt; 18 anni). BUCCOLAM deve essere usato solo da genitori\/persone che prestano assistenza in pazienti che abbiano ricevuto una diagnosi di epilessia. Per i bambini dai 3 ai 6 mesi, il trattamento deve avvenire in un ambiente ospedaliero, dove \u00e8 possibile [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/it\/portfolio\/buccolam\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm Italia\" \/>\n<meta property=\"article:modified_time\" content=\"2022-09-12T15:08:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/5\/2021\/04\/buccolam-10.png\" \/>\n\t<meta property=\"og:image:width\" content=\"920\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuraxpharm.com\/it\/portfolio\/buccolam\",\"url\":\"https:\/\/www.neuraxpharm.com\/it\/portfolio\/buccolam\",\"name\":\"Buccolam - Neuraxpharm Italia\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/it\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/it\/portfolio\/buccolam#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/it\/portfolio\/buccolam#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/5\/2021\/04\/buccolam-10.png\",\"datePublished\":\"2021-05-05T11:03:33+00:00\",\"dateModified\":\"2022-09-12T15:08:28+00:00\",\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuraxpharm.com\/it\/portfolio\/buccolam\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/www.neuraxpharm.com\/it\/portfolio\/buccolam#primaryimage\",\"url\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/5\/2021\/04\/buccolam-10.png\",\"contentUrl\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/5\/2021\/04\/buccolam-10.png\",\"width\":920,\"height\":960},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuraxpharm.com\/it\/#website\",\"url\":\"https:\/\/www.neuraxpharm.com\/it\/\",\"name\":\"Neuraxpharm Italia\",\"description\":\"A European Leader for the CNS products\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuraxpharm.com\/it\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Buccolam - Neuraxpharm Italia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/it\/portfolio\/buccolam","og_locale":"it_IT","og_type":"article","og_title":"Buccolam","og_description":"Trattamento di crisi convulsive acute prolungate, in bambini e adolescenti (da 3 mesi a &lt; 18 anni). BUCCOLAM deve essere usato solo da genitori\/persone che prestano assistenza in pazienti che abbiano ricevuto una diagnosi di epilessia. Per i bambini dai 3 ai 6 mesi, il trattamento deve avvenire in un ambiente ospedaliero, dove \u00e8 possibile [&hellip;]","og_url":"https:\/\/www.neuraxpharm.com\/it\/portfolio\/buccolam","og_site_name":"Neuraxpharm Italia","article_modified_time":"2022-09-12T15:08:28+00:00","og_image":[{"width":920,"height":960,"url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/5\/2021\/04\/buccolam-10.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Tempo di lettura stimato":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/it\/portfolio\/buccolam","url":"https:\/\/www.neuraxpharm.com\/it\/portfolio\/buccolam","name":"Buccolam - Neuraxpharm Italia","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.neuraxpharm.com\/it\/portfolio\/buccolam#primaryimage"},"image":{"@id":"https:\/\/www.neuraxpharm.com\/it\/portfolio\/buccolam#primaryimage"},"thumbnailUrl":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/5\/2021\/04\/buccolam-10.png","datePublished":"2021-05-05T11:03:33+00:00","dateModified":"2022-09-12T15:08:28+00:00","inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/it\/portfolio\/buccolam"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.neuraxpharm.com\/it\/portfolio\/buccolam#primaryimage","url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/5\/2021\/04\/buccolam-10.png","contentUrl":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/5\/2021\/04\/buccolam-10.png","width":920,"height":960},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/it\/#website","url":"https:\/\/www.neuraxpharm.com\/it\/","name":"Neuraxpharm Italia","description":"A European Leader for the CNS products","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/portfolio-products\/20948","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/portfolio-products"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/types\/portfolio-products"}],"version-history":[{"count":17,"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/portfolio-products\/20948\/revisions"}],"predecessor-version":[{"id":24668,"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/portfolio-products\/20948\/revisions\/24668"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/media\/18851"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/media?parent=20948"}],"wp:term":[{"taxonomy":"active-substance","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/active-substance?post=20948"},{"taxonomy":"product-category","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/product-category?post=20948"},{"taxonomy":"therapeutic-area","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/therapeutic-area?post=20948"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}